Clinical Trials

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04289220 2021-05-13

Anti-CD19 CAR in PiggyBac Transposon-Engineered T Cells for Relapsed/Refractory B-cell Lymphoma or B-cell Acute Lymphoblastic Leukemia

Burkitt Lymphoma, Lymphoma, B-Cell

NCT04653493 2021-03-19

CD19 Targeted CAR T Cell Therapy in Patients With Relapsed/ Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)

22 enrolled

Burkitt Lymphoma

NCT04747093 2021-02-10

Induced-T Cell Like NK Cells for B Cell Malignancies

12 enrolled

Burkitt Lymphoma, Leukemia, B-Cell, Lymphoma, B-Cell

NCT04740203 2021-02-05

Sequential CD19 and CD22 CAR-T Therapy for Newly Diagnosed Ph- B-ALL

50 enrolled

Burkitt Lymphoma

NCT03156101 2021-02-04

A Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in R/R ALL and Lymphoma Subjects

24 enrolled

Burkitt Lymphoma

NCT03265106 2021-02-04

A Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in Childhood R/R ALL and Lymphoma Subjects

Burkitt Lymphoma, Recurrence, Lymphoma, B-Cell

NCT04204161 2021-02-04

A Clinical Study of CAR-T Cells Treatment for Children With CD19+/CD22+ R/R ALL and Lymphoma

Burkitt Lymphoma, Recurrence, Lymphoma, B-Cell

NCT04723901 2021-01-26

CAR-T

Burkitt Lymphoma, Recurrence

NCT04626726 2020-11-13

Adult B-ALL Treated by CART Cell Bridging Allogeneic Hematopoietic Stem Cell Transplantation

50 enrolled

Burkitt Lymphoma

NCT03559439 2020-11-05

CD19-targeting CAR T Cells in Relapsed or Refractory CD19 Positive B-cell Malignancies

9 enrolled

Burkitt Lymphoma, Lymphoma, B-Cell

NCT04534634 2020-09-01

Study of IFN-α Combined With CAR-T Cell Therapy in Relapsed and Refractory Acute Lymphoblastic Leukemia（R/R-ALL）

Phase 2 Unknown

60 enrolled

Burkitt Lymphoma

NCT04129099 2020-05-28

A Study of GC022F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL

18 enrolled

Burkitt Lymphoma

NCT04264039 2020-02-11

Anti-CD19 U-CAR-T Cell Therapy for B Cell Hematologic Malignancies

Burkitt Lymphoma, Lymphoma, B-Cell

NCT03638206 2019-12-11

Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies

CNSDermatologicGastrointestinalGenitourinaryGynecologicLymphoidOther hematologic neoplasmOther solid neoplasmPlasma cellSarcomaThoracic

73 enrolled

Burkitt Lymphoma, Carcinoma, Renal Cell, Esophageal Neoplasms, Glioma, Carcinoma, Hepatocellular, Leukemia, Myeloid, Lung Neoplasms, Lymphoma, Melanoma, Mesothelioma, Multiple Myeloma, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Sarcoma, Synovial, Colorectal Neoplasms

NCT04191941 2019-12-10

Treatment of Hematological Malignancy With Novel CAR-T Cells.

9 enrolled

LymphoidPlasma cell

Burkitt Lymphoma, Multiple Myeloma, Lymphoma, B-Cell

NCT04184414 2019-12-03

The Clinical Application of Chimeric Antigen Receptor T Cells in the Treatment of CD19 Positive Recurrent Refractory B Cell-derived Hematological Malignancies

Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Mantle-Cell

NCT04166838 2019-11-18

The Clinical Study of CD19 UCAR-T Cells in Patients With B-cell Acute Lymphoblastic Leukemia (B-ALL)

Burkitt Lymphoma

NCT03599375 2019-02-26

Immunotherapy With CD19 CART-cells for B Cell Acute Lymphoblastic Leukemia

Burkitt Lymphoma, Leukemia, B-Cell

NCT03854994 2019-02-26

CD19 CAR-T Cell Therapy for Relapsed/Refractory B-cell Lymphoma and B-cell Acute Lymphoblastic Leukemia

Burkitt Lymphoma, Lymphoma, B-Cell

NCT03825731 2019-01-31

A Study of GC022 CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL

Burkitt Lymphoma

NCT03671460 2018-09-14

CD19 CAR-T Cells for Patients With Relapse and Refractory CD19+ B-ALL.

18 enrolled

Burkitt Lymphoma

NCT03574168 2018-06-29

CD19-CAR-T Cells in Patients With R/R B-ALL

40 enrolled

Burkitt Lymphoma

NCT03391739 2018-01-05

CCFRRBA

Phase 2/3 Unknown

Burkitt Lymphoma

NCT02924753 2017-12-29

The Safety and Efficacy of CART-19 Cells in B-cell Acute Lymphoblastic Leukemia (B-ALL).

Burkitt Lymphoma

NCT03321123 2017-10-25

MB-CART19.1 in Patients With R/R ALL

Phase 2 Unknown

Burkitt Lymphoma, Recurrence, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

NCT03263208 2017-10-20

CD19 CAR-T Cells for Patients With Relapse and Refractory CD19+ B-ALL.

Burkitt Lymphoma

NCT03298828 2017-10-02

CD19 CAR and PD-1 Knockout Engineered T Cells for CD19 Positive Malignant B-cell Derived Leukemia and Lymphoma

Burkitt Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03281551 2017-09-15

Efficacy and Safety of PZ01 Treatment in Patients With r/r CD19+ B-cell Acute Lymphoblastic Leukemia/B Cell Lymphoma

50 enrolled

Burkitt Lymphoma, Lymphoma, B-Cell

NCT02585947 2016-12-21

To Compare the Efficacy of a Prophylactic Use of Tenofovir by Duration for the Non-Hodgkin's Lymphoma

Phase 4 Unknown

90 enrolled

Burkitt Lymphoma, Lymphoma, Non-Hodgkin

NCT02968472 2016-11-18

A Phase I Trial of 4SCAR19 Cells in the Treatment of Relapsed and Refractory B Cell Leukemia

Burkitt Lymphoma, Leukemia, B-Cell

NCT02134262 2014-11-06

Gene Therapy for B-Cell Non-Hodgkin Lymphoma Using CD19 CAR Gene Transduced T Lymphocytes

18 enrolled

Burkitt Lymphoma, Immune System Diseases, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphomatoid Granulomatosis, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Experimental, Recurrence, Lymphoma, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Lymphoma, Extranodal NK-T-Cell

NCT02247609 2014-10-20

4SCAR19273